Oncolytics Biotech Inc.

ONCY ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024
Assets
Cash & Equivalents $5.2M $11.1M
Accounts Receivable — —
Inventory — —
Total Current Assets $6.8M $12.4M
Property, Plant & Equipment $228.0K $286.0K
Goodwill — —
Intangible Assets (Excl. Goodwill) — —
Total Assets $7.6M $13.4M
Liabilities
Accounts Payable $3.5M $756.0K
Total Current Liabilities $6.1M $4.9M
Long-Term Debt — —
Total Liabilities $11.4M $10.1M
Stockholders' Equity
Retained Earnings $-429.5M $-400.7M
Total Stockholders' Equity $-3.8M $3.3M